Vivanza Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Vivanza Biosciences Ltd · Outcome · 07 Nov 2026, 1:13 am
Vivanza Biosciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 1,141 (-79.4% YoY | +22.9% QoQ) ■ EBITDA: 24.1 (-60.2% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 2.1 (+102 bps YoY | Loss to Profit QoQ) ■ PAT: 13.6 (-75.8% YoY | -7.0% QoQ) ■ EPS (INR): 0.03 (-78.6% YoY | -25.0% QoQ)
Original exchange filing (PDF)
More announcements from Vivanza Biosciences Ltd
- Non-applicability of Reg 23 (9) of SEBI (LODR) Regulation, 2015 for the Quarter on 30th September, 2026. · 29 Oct 2026
- Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve unaudited standalone and .... · 03 Nov 2026
- Non applicability of the statements of Variation and Deviation under regulation 32 of SEBI LODR Regulation, 2015 as Company has not raised any further funds, hence statements of Deviation .... · 08 Oct 2026
- Voting Result for the 44th Annual General Meeting of the Company · 12 Sept 2026
- Revised Outcome of the 44th Annual General Meeting of the Vivanza Biosciences Limited · 12 Sept 2026
- Outcome of the 44th Annual General Meeting of the Members of the Vivanza Biosciences Limited. · 11 Sept 2026
- Please find enclosed newspaper advertisement w.r.t Notice of 44th AGM of the Company and e-voting information. · 20 Aug 2026
- Annual Report for the Financial Year 2025-2026 of the Company. · 19 Aug 2026
